Bonus Oct 18, 1999 Nov 05, 1999 Oct 07, 1999 Bonus Ratio: 2 share(s) for every 1 shares held Rights Feb 03, 1995 Mar 02, 1995 May 03, 1995 Rights ratio: 4 share for every 50 held at a price of Rs ...

Cipla Limited is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and ...

Cipla’s shares have surged 6% since saying last week it received final approval from the US Food and Drug Administration for its generic version of Bristol Myers Squibb’s Abraxane, a cancer ...

Cipla is currently priced at Rs 1511.40, showing a decline of 0.26% today. The 3-day exponential moving average stands at Rs 1515.16. Cipla is currently valued at Rs 1513.7, experiencing a small drop ...

Return on investment - most recent fiscal year 16.16 ...

Cipla Ltd. is a Public Limited Listed company incorporated on 17/08/1935 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is ...

The American Lung Association in New York is proud to welcome Cipla back as the lead sponsor of the 2025 LUNG FORCE Walk New York City. As this year’s Breathe Free Sponsor, Cipla continues its ...

Cipla share price: Pharmaceutical major Cipla shares were in demand on Friday, April 11, 2025, as the scrip popped up to 5.11 per cent to hit an intraday high of ₹1,488.80, upon securing USFDA ...

Cipla Foundation, along with CanSupport, have expanded free palliative home care services in Pune. With nine dedicated home care teams, the initiative will provide supportive care to more than 900 ...

Cipla, also known as Chemical, Industrial & Pharmaceutical Laboratories, is one of India’s multinational pharmaceutical companies. It was founded and chaired by K.A. Hamied in 1935, after which he was ...

Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment drug. The company has received the final approval from the US Food and ...

Pharma company Cipla has announced the date for its earnings release for the fourth quarter and full year ended March 31, 2025. In an exchange filing, the company said that a meeting of the Board of ...